Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an…
Biotechnology
US, San Diego [HQ]
Lobbying Analysis
Lobbying · US Senate · Influence
Capricor Therapeutics, Inc. has no lobbying expenses in our database.
History
DownloadFY | Quarter | Expense For Lobby Disclosure | LDA Reference |
---|---|---|---|
No data |